Organigram Global (OGI) Competitors

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Which has more volatility and risk, ACB or OGI?

Aurora Cannabis has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500.

Does the media refer more to ACB or OGI?

In the previous week, Aurora Cannabis had 8 more articles in the media than Organigram Global. MarketBeat recorded 17 mentions for Aurora Cannabis and 9 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.58 beat Aurora Cannabis' score of 0.00 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Organigram Global	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings & valuation, ACB or OGI?

Aurora Cannabis has higher revenue and earnings than Organigram Global. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$246.72M	1.20	$1.63M	-$0.19	-27.71
Organigram Global	$117.47M	1.72	-$33.39M	$0.10	15.05

Is ACB or OGI more profitable?

Organigram Global has a net margin of 2.86% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-5.66%	-1.49%	-1.06%
Organigram Global	2.86%	-8.49%	-6.08%

Do analysts prefer ACB or OGI?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Organigram Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do insiders and institutionals believe in ACB or OGI?

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Aurora Cannabis beats Organigram Global on 10 of the 16 factors compared between the two stocks.